Researchmoz Global Pvt. Ltd.

China COPD Drugs Market to Grow at a CAGR of 15.56% During Forecast Period 2016-2020

ResearchMoz added Latest Research Report titled " COPD Drugs Market in China 2016-2020: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.


Albany, NY -- (SBWIRE) -- 01/19/2017 -- Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not understood, but most cases are caused due to genetic factors and by inhaling pollutants, including smoke, fumes, and chemicals. As the disease develops, the symptoms tend to get worse and damages the lungs. The disease cannot be cured, and can only be managed and treated.

The COPD drugs market in China is under penetrated. It is dominated by fixed dose combinations of LABA/ICS. Air pollution is the major contributing factor for the growing prevalence of the disease. Nearly 10% of the population in the region who are over the age of 40 years has COPD. The disease is expected to become one of the leading causes of death in the country by 2020. Lack of awareness about the disease and its treatment options affects the growth of the market in this region.

The chronic obstructive pulmonary disease drugs market in China to grow at a CAGR of 15.56% during the period 2016-2020. The report covers the present scenario and the growth prospects of the chronic obstructive pulmonary disease drugs market in China for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of the chronic obstructive pulmonary disease drugs globally. The report does not include revenue generated from the aftermarket service of the product.

Get a Sample Research PDF with TOC:

Technavio's report, Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca
- Boehringer Ingelheim
- Merck
- Novartis

Other prominent vendors
- Ache Laboratorios Farmaceuticos
- Almirall
- Aquinox Pharmaceuticals
- Ario Pharma
- BioMarck Pharmaceuticals
- Gilead Sciences
- Mereo BioPharma Group
- Mylan
- Orion
- Pearl Therapeutics
- Prosonix
- Teva Pharmaceutical Industry
- Theravance Biopharma
- Theron Pharmaceuticals
- Verona Pharma
- Xention
- ZAI Lab

Market driver
- Increase in environmental pollution
- For a full, detailed list, view our report

Enquiry at:

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: